Induction Chemotherapy Plus Cadonilimab for Locally Advanced Cervical Cancer
Status:
RECRUITING
Trial end date:
2027-10-30
Target enrollment:
Participant gender:
Summary
This is a Phase II clinical study for patients with locally advanced cervical cancer, aimed at evaluating the efficacy, safety, and tolerability of Cadonilimab combined with chemotherapy as induction therapy.
Phase:
PHASE2
Details
Lead Sponsor:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University